Why It Matters

Doctors Hospital at Renaissance (DHR Health) operates in the Rio Grande Valley, one of the most Medicaid-dependent healthcare markets in the country. The region has at least 180,000 Medicaid enrollees, and the hospital serves a large uninsured and low-income population. Federal Medicaid funding decisions — particularly around Disproportionate Share Hospital (DSH) payments and directed payment programs — have direct consequences for the hospital's financial viability. Prior quarterly filings show the hospital lobbying consistently on Medicaid supplemental payments, DSH cuts, Medicare reimbursement rules, and the budget reconciliation process, suggesting the hospital is focused on protecting the federal funding streams that underpin its operations.

By the Numbers

A Doctors Hospital at Renaissance lobbying disclosure filed for the First Quarter of 2026 shows the South Texas hospital system reporting $80,000 in in-house lobbying activity — part of a sustained federal government relations effort that has totaled more than $680,000 in in-house spending alone over the past two years.

This first quarter 2026 LDA filing is one of two expected disclosures for this quarter. DHR Health runs a dual-track lobbying operation: an in-house effort led by lobbyist Roberto Haddad, and a separate external engagement through D. Major Group, a lobbying firm that has filed alongside the hospital each quarter.

Over the past year, the combined lobbying spend across both tracks totaled $450,000:

  • In-house (Roberto Haddad): $290,000 across four quarterly filings
  • D. Major Group (external): $160,000 across four quarterly filings

Going back further, Haddad's in-house filings alone show $680,000 in reported lobbying over nine consecutive quarterly filings dating to early 2024. Quarterly in-house spending has ranged from $70,000 to $90,000. The first quarter 2026 filing of $80,000 is consistent with that range and represents a slight uptick from the $70,000 reported in each of the prior three quarters.

The hospital has maintained a continuous lobbying presence with no gaps in quarterly filings over the tracked period, indicating a longstanding and deliberate congressional lobbying activity program rather than episodic engagement.

Haddad's congressional background is limited — he served approximately one month as a Legislative Assistant in the personal office of former Rep. Rubén Hinojosa (D-TX-15) during the 114th Congress in 2016. Hinojosa represented the Rio Grande Valley, the same region where DHR Health is based. Haddad holds a JD from Georgetown University Law Center.

The Agenda

The first quarter 2026 lobbying disclosure filing lists no specific issues or legislation — the issues field is blank. However, the hospital's prior quarterly filings establish a clear and consistent policy agenda that has evolved alongside the Congressional calendar.

Throughout 2025, the hospital lobbied on:

  • Medicaid — supplemental payments, state directed payment programs, DSH payments, provider taxes
  • Medicare — the Physician Fee Schedule, Outpatient Prospective Payment System, site neutrality, sequestration, and PAYGO
  • Federal budget and appropriations — budget reconciliation, the One Big Beautiful Bill Act (H.R. 1), the Rural Health Transformation Program, and ACA premium tax credits
  • Workforce — Graduate Medical Education funding, HRSA grants, healthcare workforce shortages, and medically underserved area designations
  • Physician-owned hospital policy

The external firm D. Major Group's filings added specific legislative references, including H.R. 1, the budget reconciliation vehicle, and H.R. 5371, the Continuing Appropriations and Extensions Act for Fiscal Year 2026. There are relevant bills moving through Congress on several of these topics that could affect hospital reimbursement and Medicaid funding structures.

Broader Context

The policy environment surrounding this healthcare lobbying activity is active. The Texas Hospital Association has warned that proposed federal Medicaid cuts could cost Texas safety-net hospitals approximately $800 million in federal fiscal year 2026 alone, with cumulative losses exceeding $2 billion over three years. DSH payments — a direct funding mechanism for hospitals serving high proportions of uninsured and Medicaid patients — are central to that concern.

KFF Health News reported that South Texas' Rio Grande Valley already operates under significant strain from uninsured patient loads, and that communities like it could face compounding difficulties under federal spending legislation. Rep. Vicente Gonzalez, whose district includes the Valley, has publicly described the region as already short approximately 1,000 physicians, adding workforce pressure to the funding picture.

DHR Health has also appeared directly in Congressional hearings. In one hearing on health care consolidation, a Member of Congress cited DHR by name, noting the hospital "was unable to expand" during the COVID-19 pandemic despite being the primary regional provider for coronavirus patients. In a separate hearing on college access, a Member referenced DHR's partnership on a nursing pipeline program designed to graduate high school students with an R.N. degree — highlighting the hospital's profile in federal workforce and education policy discussions.

The Texas Tribune reported that federal funding cuts have already had tangible effects in the Rio Grande Valley, including the cancellation of the region's largest annual free health clinic event due to reductions in state health department federal funding.

Competitive Landscape

The data available does not identify specific competing organizations lobbying on the same legislation or issue areas as DHR Health during this period. The hospital's lobbying activity, however, operates within a broader ecosystem of hospital lobbying efforts — including the Texas Hospital Association's active federal advocacy on DSH payments and Medicaid funding — that addresses many of the same policy pressure points.

The Bottom Line

DHR Health's hospital lobbying efforts reflect a consistent, well-resourced strategy to protect federal funding streams critical to a safety-net hospital in one of the country's most underserved healthcare markets. The blank issues field in the first quarter 2026 filing means the specific focus of this quarter's congressional lobbying activity is not yet public. Based on prior filings, the hospital's agenda has tracked closely with the federal budget and Medicaid policy debates dominating Congress — and those debates show no sign of slowing.

---

Access the Legis1 platform for comprehensive political news, data, and insights.